Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam bolus versus continuous infusion for induction of general anesthesia
jRCTs061230049Completed
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in None (3 arms). Primary endpoint: Time to loss of consciousness. Started Feb 2024; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCTs061230049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061230049.